Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.39 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3031215 | 0.85 | TAAR1 (0.43) | LMNATAAR1CYP2D6HTR2AHRH1 | |
| SCHEMBL169508 | 0.85 | LMNA (0.56) | LMNACCR5TAAR1CYP2D6MIF | |
| Ammonia Solution, Strong SCHEMBL1640901 | 0.82 | LMNA (0.54) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL15061554 | 0.82 | LMNA (0.45) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL536830 | 0.82 | LMNA (0.45) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL536776 | 0.82 | AOC3 (0.43) | LMNACCR5TAAR1HTR2AHRH1 | |
| Ammonia Solution, Strong SCHEMBL27550294 | 0.80 | LMNA (0.43) | LMNACCR5TAAR1CYP2D6MIF | |
| Methylamine SCHEMBL27931105 | 0.80 | LMNA (0.52) | LMNACCR5TAAR1CYP2D6HTR2A | |
| SCHEMBL3385362 | 0.79 | LMNA (0.42) | LMNACCR5TAAR1CYP2D6MIF | |
| SCHEMBL5259569 | 0.79 | POLB (0.42) | LMNAHTR2AHRH1AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 647 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240188441-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-06 | — | — | US | claimed |
| CN-1738829-B | New 2',5'-oligoadenylic acid analog | SANKYO CO | 2012-11-28 | — | — | CN | claimed |
| US-20240188441-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-06 | — | — | US | disclosed |
| CN-111919291-B | Power module | 信越化学工业株式会社 | 2024-05-17 | — | — | CN | disclosed |
| CN-117986280-A | Light-emitting device, electronic apparatus, electronic device, and condensed cyclic compound | 三星显示有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-110317453-B | Organosilicon modified polyimide resin composition | 信越化学工业株式会社 | 2024-02-13 | — | — | CN | disclosed |
| CN-113710637-B | Preparation method of biaryl phosphine | 日本化学工业株式会社 | 2023-10-24 | — | — | CN | disclosed |
| WO-2023182221-A1 | METHOD FOR PRODUCING QUANTUM DOTS | 日本化学工業株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-111655708-B | 2, 3-biphosphinopyrazine derivative, process for producing the same, complex compound, catalyst, and process for producing organoboron compound | 日本化学工业株式会社 | 2023-08-25 | — | — | CN | disclosed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| CN-116425780-A | Light-emitting device comprising condensed cyclic compound, electronic equipment and said compound | 三星显示有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-86102877-A | The method for preparing bicyclic pyrazolidinones | — | 1986-10-29 | — | — | CN | disclosed |
| CN-86103619-A | The preparation method of the bicyclic pyrazolidinones that 7-replaces | — | 1986-10-29 | — | — | CN | disclosed |
| US-4605645-A | ANTITUMOR AGENTS | TEIJIN LIMITED (JP) | 1986-08-12 | — | — | US | disclosed |
| US-4559361-A | INTRAOCULAR PRESSURE DEPRESSANTS, TREATMENT OF GLAUCOMA | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1985-12-17 | — | — | US | disclosed |
| EP-0081386-B1 | 5-FLUORO-2'-DEOXYURIDINE DERIVATIVES AND A PROCESS FOR THE PREPARATION THEREOF | TEIJIN LIMITED (JP) | 1985-05-29 | — | — | EP | disclosed |
| EP-0081386-A1 | 5-Fluoro-2'-deoxyuridine derivatives and a process for the preparation thereof | TEIJIN LIMITED (JP) | 1983-06-15 | — | — | EP | disclosed |
| US-4100089-A | High-voltage insulating material comprising anti-tracking and erosion inhibiting compounds with insulating polymers | RAYCHEM CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-3935195-A | FLUORESCENT DYE | STERLING DRUG INC. (US) | 1976-01-27 | — | — | US | disclosed |
| US-3931218-A | HYPOGLYCEMIC ANTIRESERPINE, ANTIULCER, OGENIC, ANTIARRHYTHMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240188441-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | CRY1, ELP1, CCNE2 | LMNA 1149/4885CCR5 1553/4885TAAR1 3358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.